Insight

The COVID-19 experience for patients with CNS tumors

A collage photo of Amanda King and Terri Armstrong

Aug 6, 2024, 10:37

The COVID-19 experience for patients with CNS tumors

NCI Neuro-Oncology Branch shared a paper by Amanda King et. al on X, adding:

“A study led by Terri Armstrong and Amanda King of NCI Center for Cancer Research examined the COVID-19 experience for patients with CNS tumors.

These patients experienced higher levels of depression, which could negatively influence treatment success and survival.”

COVID-19

Source: NCI Neuro-Oncology Branch/X

The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendations.

Authors: Amanda King, Kayla N Roche, Elizabeth Vera, Valentina Pillai, Lily Polskin, Alvina A Acquaye, Lisa Boris, Eric Burton, Anna Choi, Ewa Grajkowska, Heather Leeper, Marissa Panzer, Marta Penas-Prado, Jennifer Reyes, Solmaz Sahebjam, Brett J Theeler, Jing Wu, Mark R Gilbert, and Terri S Armstrong.

COVID-19

Alvina A Acquaye Amanda King Anna Choi Brett J Theeler cancer CNS tumors COVID-19 Elizabeth Vera Eric Burton Ewa Grajkowska Heather Leeper Jennifer Reyes Jing Wu Kayla N Roche Lily Polskin Lisa Boris Marissa Panzer Mark R Gilbert Marta Penas-Prado NCI NCI Center for Cancer Research NCI Neuro-Oncology Branch OncoDaily Oncology Solmaz Sahebjam Terri Armstrong Terri S Armstrong Valentina Pillai

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage